Add to ORKGin the progression of cardiovascular disease in patients with CKD. Further studies are needed to better characterize the impact of these compounds on cardiovascular outcomes. Beneficial treatments are currently available that, in prelimi-nary studies, appear to neutralize some of the adverse ef-fects of uremic toxins. Large randomized clinical trials are needed to further determine the utility of these varied ther-apeutic agents. Copyright © 2013 S. Karger AG, Base
Progress in the identification and characterization of uremic retention solutes has refined our unde...
Topics covered in this review include the relation of esti-mated glomerular filtration rate, protein...
Reviewing the current picture of uremic toxicity reveals its complexity. Focusing on cardiovascular ...
BackgroundRetention of uremic toxins in patients with chronic kidney disease (CKD) negatively affect...
Subjects with chronic kidney disease (CKD) are at risk of cardiovascular diseases and suffer from ac...
The importance of uremic toxin (UTx) removal in chronic kidney disease (CKD) is an emerging topic in...
Cardiovascular disease (CVD) is highly prevalent in the setting of chronic kidney disease (CKD). Suc...
International audiencePatients with chronic kidney disease (CKD) have an elevated prevalence of athe...
International audienceChronic kidney disease (CKD) is classified into five stages with kidney failur...
Patients with chronic kidney disease (CKD) are at a highly increased risk of cardiovascular complica...
In the review, the author returns to the topic of uremia and uremic toxins, their importance for pra...
Uremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to ...
Chronic kidney disease (CKD) prevalence is high and constantly increasing over the last years across...
Chronic kidney disease is a growing public health problem, as its prevalence and incidence have almo...
Cardiovascular disease (CVD) remains a major cause of high morbidity and mortality in patients with ...
Progress in the identification and characterization of uremic retention solutes has refined our unde...
Topics covered in this review include the relation of esti-mated glomerular filtration rate, protein...
Reviewing the current picture of uremic toxicity reveals its complexity. Focusing on cardiovascular ...
BackgroundRetention of uremic toxins in patients with chronic kidney disease (CKD) negatively affect...
Subjects with chronic kidney disease (CKD) are at risk of cardiovascular diseases and suffer from ac...
The importance of uremic toxin (UTx) removal in chronic kidney disease (CKD) is an emerging topic in...
Cardiovascular disease (CVD) is highly prevalent in the setting of chronic kidney disease (CKD). Suc...
International audiencePatients with chronic kidney disease (CKD) have an elevated prevalence of athe...
International audienceChronic kidney disease (CKD) is classified into five stages with kidney failur...
Patients with chronic kidney disease (CKD) are at a highly increased risk of cardiovascular complica...
In the review, the author returns to the topic of uremia and uremic toxins, their importance for pra...
Uremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to ...
Chronic kidney disease (CKD) prevalence is high and constantly increasing over the last years across...
Chronic kidney disease is a growing public health problem, as its prevalence and incidence have almo...
Cardiovascular disease (CVD) remains a major cause of high morbidity and mortality in patients with ...
Progress in the identification and characterization of uremic retention solutes has refined our unde...
Topics covered in this review include the relation of esti-mated glomerular filtration rate, protein...
Reviewing the current picture of uremic toxicity reveals its complexity. Focusing on cardiovascular ...